（记者 王晓波） 每经AI快讯，有投资者在投资者互动平台提问：当地时间9月24日，印尼格拉斯伯格矿区运营方、美国 矿业巨头自由港-麦克莫兰铜金公司宣布，因山体滑坡导致矿难，预计三季度铜销售额将因此下滑，全 面复工时间推迟至2026年上半年。受此影响，国际铜价应声走高，纽约铜期货价格创下两个月来新高。 公司拥有巨多矿产资源，请问具体开发情况，能给公司带来多少收益？ 和邦生物（603077.SH）9月26日在投资者互动平台表示，2025年上半年，矿业板块为公司合计产生利 润超过1.42亿元，其中磷矿已成为最大的利润贡献来源，磷矿石销售持续维持高景气度，产销两旺、量 价均高：马边烟峰磷矿在上半年实现销售约40.81万吨；汉源刘家山磷矿已有稳定的工程矿采出，公司 加大下游客户的开发和跟踪，预计刘家山磷矿形成销售后将继续为公司增厚利润；澳洲AEV磷矿按照 既定的工作目标全面推进，预计2025年年底产出工程矿。 澳洲金矿项目初勘工作已完成，目前AEV管 理层正在评估初勘数据并根据该数据筹划下一步勘探工作。新疆的铜矿、铅锌矿的初勘工作仍在持续 中，公司的勘探团队克服了高海拔、缺氧等恶劣作业环境的条件，按计划推进钻槽工作。 ...

资金面上看，今日草甘膦概念板块获主力资金净流入0.20亿元，其中，8股获主力资金净流入，净流入 资金居首的是利尔化学，今日主力资金净流入1329.97万元，净流入资金居前的还有和邦生物、江天化 学、扬农化工等，主力资金分别净流入1025.24万元、754.49万元、312.50万元。 资金流入比率方面，江天化学、和邦生物、安道麦A等流入比率居前，主力资金净流入率分别为 10.43%、6.41%、3.60%。（数据宝） 草甘膦概念资金流入榜 | 代码 | 简称 | 今日涨跌幅 | 今日换手率 | 主力资金流量（万 | 主力资金净流入比率 | | --- | --- | --- | --- | --- | --- | | | | （%） | （%） | 元） | （%） | | 002258 | 利尔化 学 | 6.17 | 5.86 | 1329.97 | 2.21 | | 603077 | 和邦生 物 | 0.00 | 0.95 | 1025.24 | 6.41 | | 300927 | 江天化 学 | 0.67 | 1.99 | 754.49 | 10.43 | | 600486 | 扬农化 工 | 2.1 ...

Core Viewpoint - The continuous expansion of crop planting area in China is driving the growth of the herbicide market, with increasing demand for long-lasting herbicides in non-agricultural sectors such as railways and industrial parks, leading companies to develop environmentally friendly formulations with a duration of over six months [1][9]. Summary by Sections Overview - The herbicide market is defined under the revised "Pesticide Management Regulations" by the State Council, which categorizes herbicides as substances used to suppress or kill weeds, thereby protecting crops [2]. - There are over 300 types of herbicides, classified into thirteen categories based on their chemical structure [2]. Industry Chain - The upstream of the herbicide industry includes suppliers of petrochemical raw materials, inorganic chemicals, and production equipment, while the midstream consists of glyphosate processing enterprises, and the downstream primarily serves agricultural and non-agricultural weed control markets [7][8]. Current Development - The total production of agricultural raw materials in China is projected to reach 3.3126 million tons in 2024, with herbicides accounting for 1.2719 million tons, representing 38.40% of the total [1][9]. - The demand for herbicides is expected to grow due to the continuous increase in crop planting area, which reached 173 million hectares in 2024, with various crops showing positive growth rates [8]. Import and Export Trade - In 2024, China's herbicide exports are expected to reach 2.1244 million tons, generating an export revenue of approximately $5.085 billion, with retail packaging accounting for 57.21% of the exports [10]. Competitive Landscape - The herbicide market in China is characterized by the coexistence of domestic and foreign companies, with leading firms like Bayer, Syngenta, and BASF holding significant market shares, while domestic companies such as Adama, Xingfa Group, and New Hope Group have also enhanced their market competitiveness [11]. Key Companies - Adama's revenue in 2024 is projected to exceed 29.49 billion yuan, with herbicide sales contributing 39.77% of its total revenue [11]. - New Hope Group is expected to achieve a revenue of 14.67 billion yuan in 2024, with a gross profit margin of 11.07% [12]. Future Trends - The future of the herbicide industry may see the integration of drone technology for real-time weed monitoring and targeted application, as well as a shift towards a closed-loop ecosystem that encompasses research, production, service, and recycling [13].

Group 1 - The chemical sector experienced a volatile upward trend on September 15, with the Chemical ETF (516020) closing up by 0.13% [1] - Key stocks in the lithium battery, titanium dioxide, and fluorochemical sectors saw significant gains, with Tianqi Lithium hitting the daily limit, Longbai Group rising by 5.09%, and multiple other companies increasing by over 3% [1][3] - Analysts attribute the surge in the lithium battery sector to four main positive drivers, including new payment norms from the China Automotive Industry Association and a recent action plan for green transformation in Fujian [3] Group 2 - The recent issuance of the "New Energy Storage Scale Construction Special Action Plan (2025-2027)" by the National Development and Reform Commission and the Energy Administration has contributed to market optimism [3] - The Ministry of Industry and Information Technology and other departments have jointly issued a growth plan for the automotive industry, aiming for approximately 32.3 million vehicle sales in 2025, including 15.5 million new energy vehicles [3] - The chemical ETF (516020) is currently at a low valuation, with a price-to-book ratio of 2.29, indicating a favorable long-term investment opportunity [3] Group 3 - Guohai Securities suggests that the Chinese chemical industry may undergo a revaluation, with potential for increased cash flow and higher dividend yields as global capacity expansion slows [4] - The outlook for the second half of 2025 indicates that fiscal policies in China and the U.S. may strengthen, leading to a potential upturn in the chemical sector [5] - The chemical ETF (516020) provides a diversified investment approach, covering various sub-sectors and focusing on large-cap leading stocks, which may enhance investment efficiency [5]

Group 1 - The company does not currently have products directly used in solid-state batteries, but its sodium carbonate and phosphate products are basic raw materials for some solid-state battery cathodes [1] - The company holds a 50% stake in Nigeria's BCT Company through its wholly-owned subsidiary, Hebang Bio (Hong Kong) Investment Co., Ltd [1] - BCT Company is primarily engaged in the mining, washing, and sales of lithium and tin ores, currently holding exploration rights for 15 lithium mines and 6 tin mines [1] Group 2 - BCT Company controls 60% of "Deep Earth Mineral Resources Limited," which has exploration rights for 5 lithium mines, and "BC Mining Company Limited," which has exploration rights for 2 lithium mines [1]

Core Points - Hebang Biotechnology announced the need to pay corporate income tax and late fees totaling 71,473,969.37 yuan for the period from January 1, 2023, to December 31, 2023 [1] - As of the date of the announcement, the company has completed the payment of the aforementioned tax and late fees, and this matter does not involve any administrative penalties [1]

Market Performance - The agricultural chemical sector increased by 0.64% on September 11, with Dongfang Tieta leading the gains [1] - The Shanghai Composite Index closed at 3875.31, up 1.65%, while the Shenzhen Component Index closed at 12979.89, up 3.36% [1] Stock Performance - Dongfang Tieta (002545) closed at 12.96, up 6.23% with a trading volume of 487,700 shares and a transaction value of 623 million [1] - Bai'ao Chemical (603360) closed at 25.20, up 2.56% with a trading volume of 150,100 shares and a transaction value of 373 million [1] - Other notable stocks include Yaji International (000893) at 38.46, up 2.04%, and Beisimei (300796) at 10.53, up 2.03% [1] Capital Flow - The agricultural chemical sector experienced a net outflow of 281 million from institutional investors, while retail investors saw a net inflow of 153 million [2] - The sector's overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors are actively buying [2] Individual Stock Capital Flow - Yanhai Co. (000792) had a net inflow of 99.18 million from institutional investors, while it faced a net outflow of 62.99 million from speculative funds [3] - Bai'ao Chemical (603360) saw a net inflow of 18.38 million from institutional investors but a net outflow of 24.29 million from speculative funds [3] - Guotian Co. (002170) had a net inflow of 8.12 million from institutional investors, with a significant net inflow of 46.84 million from speculative funds [3]

和邦生物（603077）(603077.SH)发布公告，经自查，公司需补缴2023年1月1日至2023年12月31日企业 所得税及滞纳金合计7147.4万元。截至本公告披露日，公司已将上述税款及滞纳金缴纳完毕，本事项不 涉及行政处罚。 公司补缴上述税款及滞纳金将计入2025年当期损益，预计将影响公司2025年度归属于上市公司股东的净 利润7147.4万元，最终以2025年度经审计的财务报表为准。 ...

和邦生物(603077.SH)发布公告，经自查，公司需补缴2023年1月1日至2023年12月31日企业所得税及滞 纳金合计7147.4万元。截至本公告披露日，公司已将上述税款及滞纳金缴纳完毕，本事项不涉及行政处 罚。 公司补缴上述税款及滞纳金将计入2025年当期损益，预计将影响公司2025年度归属于上市公司股东的净 利润7147.4万元，最终以2025年度经审计的财务报表为准。 ...

| 证券代码：603077 | 证券简称：和邦生物 | 公告编号：2025-043 | | --- | --- | --- | | 债券代码：113691 | 债券简称：和邦转债 | | 四川和邦生物科技股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2025 年 09 月 15 日（星期一）至 09 月 19 日（星期五）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 jsy@hebang.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 四川和邦生物科技股份有限公司（以下简称"公司"）已于 2025 年 8 月 20 日发布《四川和邦生物科技股份有限公司 2025 年半年度报告》，为便于广大投资 者更全面深入地了解公司 2025 年半年度经营成果、财务状况，公司计划于 2025 年 09 月 22 日（星期一）16:00-17:00 举行 2025 年半年度业绩说明会，就投资 者关心的问题进 ...